company background image
600380 logo

Joincare Pharmaceutical Group IndustryLtd SHSE:600380 Stock Report

Last Price

CN¥11.17

Market Cap

CN¥20.9b

7D

-2.6%

1Y

-11.9%

Updated

23 Nov, 2024

Data

Company Financials +

Joincare Pharmaceutical Group Industry Co.,Ltd.

SHSE:600380 Stock Report

Market Cap: CN¥20.9b

600380 Stock Overview

Joincare Pharmaceutical Group Industry Co.,Ltd. More details

600380 fundamental analysis
Snowflake Score
Valuation5/6
Future Growth1/6
Past Performance4/6
Financial Health5/6
Dividends5/6

Joincare Pharmaceutical Group Industry Co.,Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Joincare Pharmaceutical Group IndustryLtd
Historical stock prices
Current Share PriceCN¥11.17
52 Week HighCN¥13.25
52 Week LowCN¥9.40
Beta0.44
11 Month Change3.23%
3 Month Change11.59%
1 Year Change-11.91%
33 Year Change-7.61%
5 Year Change13.75%
Change since IPO3.92%

Recent News & Updates

Is Joincare Pharmaceutical Group IndustryLtd (SHSE:600380) A Risky Investment?

Nov 17
Is Joincare Pharmaceutical Group IndustryLtd (SHSE:600380) A Risky Investment?

Recent updates

Is Joincare Pharmaceutical Group IndustryLtd (SHSE:600380) A Risky Investment?

Nov 17
Is Joincare Pharmaceutical Group IndustryLtd (SHSE:600380) A Risky Investment?

Joincare Pharmaceutical Group Industry Co.,Ltd.'s (SHSE:600380) Business And Shares Still Trailing The Market

Aug 13
Joincare Pharmaceutical Group Industry Co.,Ltd.'s (SHSE:600380) Business And Shares Still Trailing The Market

We Think Joincare Pharmaceutical Group IndustryLtd (SHSE:600380) Can Manage Its Debt With Ease

Jun 23
We Think Joincare Pharmaceutical Group IndustryLtd (SHSE:600380) Can Manage Its Debt With Ease

Shareholders Will Probably Hold Off On Increasing Joincare Pharmaceutical Group Industry Co.,Ltd.'s (SHSE:600380) CEO Compensation For The Time Being

May 31
Shareholders Will Probably Hold Off On Increasing Joincare Pharmaceutical Group Industry Co.,Ltd.'s (SHSE:600380) CEO Compensation For The Time Being

Joincare Pharmaceutical Group IndustryLtd's (SHSE:600380) Conservative Accounting Might Explain Soft Earnings

Apr 09
Joincare Pharmaceutical Group IndustryLtd's (SHSE:600380) Conservative Accounting Might Explain Soft Earnings

Investors Don't See Light At End Of Joincare Pharmaceutical Group Industry Co.,Ltd.'s (SHSE:600380) Tunnel

Mar 04
Investors Don't See Light At End Of Joincare Pharmaceutical Group Industry Co.,Ltd.'s (SHSE:600380) Tunnel

Shareholder Returns

600380CN PharmaceuticalsCN Market
7D-2.6%-1.5%-2.1%
1Y-11.9%-9.4%2.8%

Return vs Industry: 600380 underperformed the CN Pharmaceuticals industry which returned -9.4% over the past year.

Return vs Market: 600380 underperformed the CN Market which returned 2.8% over the past year.

Price Volatility

Is 600380's price volatile compared to industry and market?
600380 volatility
600380 Average Weekly Movement5.5%
Pharmaceuticals Industry Average Movement7.4%
Market Average Movement8.4%
10% most volatile stocks in CN Market12.7%
10% least volatile stocks in CN Market5.7%

Stable Share Price: 600380 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 600380's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199214,365Xiong Yuwww.joincare.com

Joincare Pharmaceutical Group Industry Co.,Ltd. engages in the research, development, production, and sale of pharmaceuticals and health care products primarily in China. The company offers chemical preparation for drugs, including digestive tract, cardiovascular and cerebrovascular, antimicrobial, anti-tumor, assisted reproductive, neurological therapeutic, OCT, and other drugs; and traditional Chinese drug preparation production, which includes anti-tumor and cold products.

Joincare Pharmaceutical Group Industry Co.,Ltd. Fundamentals Summary

How do Joincare Pharmaceutical Group IndustryLtd's earnings and revenue compare to its market cap?
600380 fundamental statistics
Market capCN¥20.93b
Earnings (TTM)CN¥1.47b
Revenue (TTM)CN¥15.89b

14.2x

P/E Ratio

1.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
600380 income statement (TTM)
RevenueCN¥15.89b
Cost of RevenueCN¥6.16b
Gross ProfitCN¥9.73b
Other ExpensesCN¥8.26b
EarningsCN¥1.47b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Nov 25, 2024

Earnings per share (EPS)0.78
Gross Margin61.21%
Net Profit Margin9.25%
Debt/Equity Ratio22.7%

How did 600380 perform over the long term?

See historical performance and comparison

Dividends

1.6%

Current Dividend Yield

23%

Payout Ratio